Alternatives to Caris Life Sciences
The top Biotech companies similar to Caris Life Sciences, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Human Longevity63HealthTechSan Diego, United StatesGenomics and AI-driven health intelligence company focused on extending healthy human life.
- Website
BIOCAPTIVA41BiotechnologyEdinburgh, United Kingdom$5.6MA biotech spin-out from the University of Edinburgh developing novel bioprocessing solutions.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Cellcolabs55BiotechTel Aviv, Israel$15.5MAI-powered platform for personalized cell therapy development and manufacturing.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Syantra53BiotechCalgary, Canada$3.6MA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
- Website RERetro Biosciences48BiotechRedwood City, United States$180.0M
A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website
Alto Neuroscience43BiotechLos Altos, United States$370.0MAlto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
- Website
AbCellera41BiotechVancouver, Canada$10.0MAI-powered platform for antibody discovery and development to create new medicines.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Nona Biosciences62BiotechShanghai, ChinaBiotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Tekhnovo46BiotechHollister, United KingdomTeknova provides critical reagents for biopharmaceutical product development and production.
- Website
Moleculent61BiotechStockholm, Sweden$46.0MMapping cell-cell communication at scale in human tissue.
- Website
Deep Genomics61BiotechToronto, Canada$241.0MAI-powered biotechnology company developing RNA therapeutics for genetic diseases.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Relay Therapeutics58BiotechCambridge, United States$825.0MClinical-stage precision medicine company using protein motion insights for drug discovery.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Ultragenyx55BiotechNovato, United States$100.0MBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
Triomics53BiotechCambridge, United States$22.0MAdvance every cancer decision.
- Website
Bluebird Bio51BiotechSomerville, United States$1.0BGene therapy company developing transformative treatments for severe genetic diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website
Grundium71HealthTechTampere, Finland$48.0MDigital pathology imaging technology and AI-driven precision pathology software.
- Website Peptaris, .36BiotechCambridge, United States
Mining biological information for transformative peptide medicines.
- Website
PFx Biotech51BiotechCambridge, United States$5.2MPFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.
- Website
One Biosciences35BiotechParis, FranceOne Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.
- Website Maas Biolabs35Biotech
- Website
Leap Therapeutics50BiotechCambridge, United States$189.0MLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
- Website RIRidge Bio50BiotechSan Francisco, United States$135.0M
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
- Website
C4 Therapeutics49BiotechBoston, United States$371.0MBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
MacroGenics49BiotechRockville, United States$13.5MBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website CSCSF Biosciences48BiotechCambridge, United States$15.0M
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
- Website LELeman Biotech48BiotechShenzhen, China$22.7M
Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.
- Website
Ipsen33BiotechParis, FranceGlobal biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
- Website
CytoReason68HealthcareTel Aviv, Israel$128.3MDevelops a computational model of the human body for drug discovery and development.
- Website
Benchling66BIO + LIFE SCIENCESSan Francisco, United States$419.0MR&D cloud platform for life sciences, enabling scientific innovation and productivity.
- Website
iSpecimen .46BiotechPlainsboro, United States$1.0MGlobal marketplace connecting researchers with human biospecimens for life science research.
- Website ALAlpha9 Theranostics44BiotechVancouver, Canada$10.0M
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
- Website
DeepCure63HealthcareTel Aviv, Israel$65.4MAI-driven drug discovery platform accelerating breakthrough scientific research.
- Website
Nucleai63HealthcareTel Aviv, Israel$58.5MAI-powered spatial biology platform for precision medicine and drug development.
- Website
Imagene62HealthcareTel Aviv, Israel$44.5MAI-powered platform for profiling cancer biomarkers from digitized biopsy images.
- Website
Xinteza API42BiotechSan Francisco, United States$10.0MBiosynthesis of cannabinoids and psychedelics using advanced biotechnology.
- Website
32 Biosciences42BiotechSan Diego, United States$12.0MDevelops novel therapeutic antibodies for oncology and autoimmune diseases.
- Website
Insitro62HealthcareSouth San Francisco, United States$243.0MData-driven drug discovery and development company using machine learning and high-throughput biology.
- Website BIBiolojic Design, Ltd.42BiotechRehovot, Israel$10.0M
Biotech company focused on designing and developing novel biological solutions.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Genoox62HealthcarePalo Alto, United States$20.0MGenoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.
- Website
Lunit61HealthTechSeoul, South Korea$1.1BLunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.
Compare Caris Life Sciences head to head
Side by side on what each one does, what it costs, and what real users report.
- Caris Life Sciences vs Guardant Health
- Caris Life Sciences vs Human Longevity
- Caris Life Sciences vs BIOCAPTIVA
- Caris Life Sciences vs Adaptive Biotechnologies
- Caris Life Sciences vs BeiGene
- Caris Life Sciences vs BioSymetrics
- Caris Life Sciences vs Cue Biopharma, .
- Caris Life Sciences vs Cellcolabs
- Caris Life Sciences vs ProteinQure
- Caris Life Sciences vs Avidity Biosciences

